Skip to main content
Erschienen in: Digestive Diseases and Sciences 8/2016

18.03.2016 | Original Article

Significant Association Between Gallstone Disease and Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis

verfasst von: Veeravich Jaruvongvanich, Anawin Sanguankeo, Sikarin Upala

Erschienen in: Digestive Diseases and Sciences | Ausgabe 8/2016

Einloggen, um Zugang zu erhalten

Abstract

Background

Gallstone disease (GD) and nonalcoholic fatty liver disease (NAFLD) are common digestive disorders worldwide. Both conditions share certain risk factors including obesity, insulin resistance and diabetes. Several epidemiologic studies have reported the relationship between these two conditions.

Aim

We conducted a systematic review and meta-analysis to characterize the association between GD and NAFLD.

Methods

A comprehensive search of the databases MEDLINE and EMBASE was performed from inception through November 2015. The inclusion criterion was the observational studies’ assessment of the association between GD and NAFLD in adult participants. Pooled odds ratio (OR) and 95 % confidence interval (CI) were calculated using a random-effects model.

Results

Data were extracted from 12 observational studies (9 cross-sectional studies, 1 case–control study and 2 cohort studies). The pooled OR of NAFLD in patients who had GD was 1.55 (95 % CI 1.31–1.82). The statistical between-studies heterogeneity (I 2) was 64 %. The association remained significant when limited to cohort studies with pooled OR 1.33 (95 % CI 1.14–1.55, I 2 = 0 %).

Conclusion

Our meta-analysis demonstrated that GD is significantly associated with NAFLD. Further prospective studies exploring the underlying mechanism of this association should be pursued.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
2.
Zurück zum Zitat Sakorafas GH, Milingos D, Peros G. Asymptomatic cholelithiasis: is cholecystectomy really needed? A critical reappraisal 15 years after the introduction of laparoscopic cholecystectomy. Dig Dis Sci. 2007;52:1313–1325. doi:10.1007/s10620-006-9107-3.CrossRefPubMed Sakorafas GH, Milingos D, Peros G. Asymptomatic cholelithiasis: is cholecystectomy really needed? A critical reappraisal 15 years after the introduction of laparoscopic cholecystectomy. Dig Dis Sci. 2007;52:1313–1325. doi:10.​1007/​s10620-006-9107-3.CrossRefPubMed
3.
Zurück zum Zitat Sandler RS, Everhart JE, Donowitz M, et al. The burden of selected digestive diseases in the United States. Gastroenterology. 2002;122:1500–1511.CrossRefPubMed Sandler RS, Everhart JE, Donowitz M, et al. The burden of selected digestive diseases in the United States. Gastroenterology. 2002;122:1500–1511.CrossRefPubMed
8.
Zurück zum Zitat Ata N, Kucukazman M, Yavuz B, et al. The metabolic syndrome is associated with complicated gallstone disease. Can J Gastroenterol. 2011;25:274–276.CrossRefPubMedPubMedCentral Ata N, Kucukazman M, Yavuz B, et al. The metabolic syndrome is associated with complicated gallstone disease. Can J Gastroenterol. 2011;25:274–276.CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Misciagna G, Guerra V, Di Leo A, Correale M, Trevisan M. Insulin and gall stones: a population case control study in southern Italy. Gut. 2000;47:144–147.CrossRefPubMedPubMedCentral Misciagna G, Guerra V, Di Leo A, Correale M, Trevisan M. Insulin and gall stones: a population case control study in southern Italy. Gut. 2000;47:144–147.CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Tsai CJ, Leitzmann MF, Willett WC, Giovannucci EL. Prospective study of abdominal adiposity and gallstone disease in US men. Am J Clin Nutr. 2004;80:38–44.PubMed Tsai CJ, Leitzmann MF, Willett WC, Giovannucci EL. Prospective study of abdominal adiposity and gallstone disease in US men. Am J Clin Nutr. 2004;80:38–44.PubMed
12.
16.
Zurück zum Zitat Froutan Y, Alizadeh A, Mansour-Ghanaei F, et al. Gallstone disease founded by ultrasonography in functional dyspepsia: prevalence and associated factors. Int J Clin Exp Med. 2015;8:11283–11288.PubMedPubMedCentral Froutan Y, Alizadeh A, Mansour-Ghanaei F, et al. Gallstone disease founded by ultrasonography in functional dyspepsia: prevalence and associated factors. Int J Clin Exp Med. 2015;8:11283–11288.PubMedPubMedCentral
19.
20.
Zurück zum Zitat Lu SN, Chang WY, Wang LY, et al. Risk factors for gallstones among Chinese in Taiwan. A community sonographic survey. J Clin Gastroenterol. 1990;12:542–546.CrossRefPubMed Lu SN, Chang WY, Wang LY, et al. Risk factors for gallstones among Chinese in Taiwan. A community sonographic survey. J Clin Gastroenterol. 1990;12:542–546.CrossRefPubMed
26.
Zurück zum Zitat Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group. Jama. 2000;283:2008–2012.CrossRefPubMed Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group. Jama. 2000;283:2008–2012.CrossRefPubMed
29.
Zurück zum Zitat Sterne JA, Egger M. Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis. J Clin Epidemiol. 2001;54:1046–1055.CrossRefPubMed Sterne JA, Egger M. Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis. J Clin Epidemiol. 2001;54:1046–1055.CrossRefPubMed
35.
Zurück zum Zitat Nakeeb A, Comuzzie AG, Al-Azzawi H, Sonnenberg GE, Kissebah AH, Pitt HA. Insulin resistance causes human gallbladder dysmotility. J Gastrointest Surg. 2006;10:940–948; discussion 948-949. doi:10.1016/j.gassur.2006.04.005. Nakeeb A, Comuzzie AG, Al-Azzawi H, Sonnenberg GE, Kissebah AH, Pitt HA. Insulin resistance causes human gallbladder dysmotility. J Gastrointest Surg. 2006;10:940–948; discussion 948-949. doi:10.​1016/​j.​gassur.​2006.​04.​005.
37.
Zurück zum Zitat Grundy SM. Cholesterol gallstones: a fellow traveler with metabolic syndrome? Am J Clin Nutr. 2004;80:1–2.PubMed Grundy SM. Cholesterol gallstones: a fellow traveler with metabolic syndrome? Am J Clin Nutr. 2004;80:1–2.PubMed
39.
Zurück zum Zitat Renner O, Harsch S, Matysik S, Lutjohann D, Schmitz G, Stange EF. Upregulation of hepatic bile acid synthesis via fibroblast growth factor 19 is defective in gallstone disease but functional in overweight individuals. United Eur Gastroenterol J. 2014;2:216–225. doi:10.1177/2050640614527938.CrossRef Renner O, Harsch S, Matysik S, Lutjohann D, Schmitz G, Stange EF. Upregulation of hepatic bile acid synthesis via fibroblast growth factor 19 is defective in gallstone disease but functional in overweight individuals. United Eur Gastroenterol J. 2014;2:216–225. doi:10.​1177/​2050640614527938​.CrossRef
41.
Zurück zum Zitat Chalasani N, Younossi Z, Lavine JE. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology. Gastroenterology. 2012;142:1592–1609. doi:10.1053/j.gastro.2012.04.001.CrossRefPubMed Chalasani N, Younossi Z, Lavine JE. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology. Gastroenterology. 2012;142:1592–1609. doi:10.​1053/​j.​gastro.​2012.​04.​001.CrossRefPubMed
45.
Zurück zum Zitat Kullak-Ublick GA, Paumgartner G, Berr F. Long-term effects of cholecystectomy on bile acid metabolism. Hepatology. 1995;21:41–45.CrossRefPubMed Kullak-Ublick GA, Paumgartner G, Berr F. Long-term effects of cholecystectomy on bile acid metabolism. Hepatology. 1995;21:41–45.CrossRefPubMed
46.
Zurück zum Zitat Zweers SJ, Booij KA, Komuta M, et al. The human gallbladder secretes fibroblast growth factor 19 into bile: towards defining the role of fibroblast growth factor 19 in the enterobiliary tract. Hepatology. 2012;55:575–583. doi:10.1002/hep.24702.CrossRefPubMed Zweers SJ, Booij KA, Komuta M, et al. The human gallbladder secretes fibroblast growth factor 19 into bile: towards defining the role of fibroblast growth factor 19 in the enterobiliary tract. Hepatology. 2012;55:575–583. doi:10.​1002/​hep.​24702.CrossRefPubMed
Metadaten
Titel
Significant Association Between Gallstone Disease and Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis
verfasst von
Veeravich Jaruvongvanich
Anawin Sanguankeo
Sikarin Upala
Publikationsdatum
18.03.2016
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 8/2016
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-016-4125-2

Weitere Artikel der Ausgabe 8/2016

Digestive Diseases and Sciences 8/2016 Zur Ausgabe

UNM Clinical Case Conferences

Trouble Spotted in the Liver!

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.